Passage Bio, Inc. (PASG) Financials
PASG Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 169.3 million | 43.0 million |
2023-06-30 | 193.7 million | 43.3 million |
2023-03-31 | 213.2 million | 42.9 million |
2022-12-31 | 243.5 million | 42.2 million |
PASG Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -19.2 million | 2.8 million |
2023-06-30 | -17.2 million | 3.7 million |
2023-03-31 | -22.5 million | 2.8 million |
2022-12-31 | -24.5 million | 3.5 million |
PASG Net Income
No data available :(
PASG Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 132.8 million | - | 26.5 million |
2023-06-30 | 151.5 million | - | 26.7 million |
2023-03-31 | 167.8 million | - | 27.0 million |
2022-12-31 | 189.6 million | - | 27.1 million |
PASG Shares Outstanding
PASG Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 4000 | 15.1 million | 8.2 million | - |
2023-06-30 | 103000 | 17.3 million | 8.1 million | - |
2023-03-31 | 26000 | 16.8 million | 19.0 million | - |
2022-12-31 | 474000 | 17.7 million | 10.6 million | - |
PASG Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 1.0 million |
2023-06-30 | - | 978000 |
2023-03-31 | - | 978000 |
2022-12-31 | - | 946000 |
PASG
Price: $1.35
52 week price:
Earnings Per Share: -1.86 USD
P/E Ratio: -0.49
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 271900
Market Capitalization: 73.4 million